RBC halves its SFM target as shorts stay elevated post-earnings

Sprouts Farmers Market reported Q3 earnings on October 29. The stock fell 25% the following day. Short interest sits at 12.6% of the free float, still up 1.8% over the past month despite a 6.7% single-day pullback in borrowed shares on October 30.

Wall Street cuts deep

Five firms lowered their price targets in the 24 hours after the print. The sharpest cut came from RBC Capital's Steven Shemesh, who downgraded the stock to Sector Perform and slashed his target from $111 to $49, citing Cyclospora's lingering drag on produce comps and a fuel-driven $5M EBIT headwind. Goldman Sachs's Kate McShane kept her Buy rating but cut from $94 to $58. JP Morgan's Thomas Palmer held Overweight while dropping from $90 to $58. Barclays and Wells Fargo both maintained Overweight but reduced targets to $65 and $60 respectively, from $100 each.

The consensus mean target now stands at $63.29 against a last close of $49.70. The stock is off 25% over the past week, against a median of roughly flat for its closest peers.

Short interest: elevated but easing

Short sellers built positions ahead of the print. Borrowed shares peaked around 14.4 million on October 23, representing roughly 14.8% of the free float. By October 30 that had fallen to 12.3 million shares, 12.6% of float. The month-over-month figure is still positive, up 1.8%, which means the net positioning from a month ago remains bearish even after the post-earnings partial unwind.

Borrow availability sits at 111%, meaning slightly more shares are available to lend than are currently borrowed. Cost to borrow is 0.54%, near its lowest level in recent months. The lending market is not tight. New short positions remain cheap and easy to establish.

Options settled after the spike

The put/call ratio reached 0.66 on October 29, 2.4 standard deviations above its 20-day mean of 0.58. That was the defensive peak. By October 30, the ratio had retreated to 0.54, back below the 20-day average. The elevated put demand before earnings proved prescient. The 52-week high on the PCR is 0.9975, so even at the pre-earnings peak, options positioning was far from its most extreme.

The bear case in focus

The analyst bear case centres on three overlaps: Cyclospora depressing produce comps below pre-outbreak levels as of late September, elevated fuel costs adding a roughly $2.5M quarterly EBIT drag, and competitive pressure as traditional grocers expand health-and-wellness ranges. The ORTEX short score stood at 71.9 on October 29. CEO Jack Sinclair's recent trades were all made under a pre-arranged 10b5-1 plan, so carry limited informational weight.

Key data as of October 30: SI 12.6% of free float, down 6.7% in one day but up 1.8% over one month. Cost to borrow 0.54%. Borrow availability 111%. Put/call ratio 0.54. Consensus target $63.29, five of the past six analyst actions were target cuts.